| Literature DB >> 32500135 |
Lisa Glance Mostafavifar1, Lindsey T Groff1.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 32500135 PMCID: PMC7314111 DOI: 10.1093/ajhp/zxaa126
Source DB: PubMed Journal: Am J Health Syst Pharm ISSN: 1079-2082 Impact factor: 2.637
Pharmacy Resident COVID-19 Contributions
| Initiative | Contribution(s) | Resident Group |
|---|---|---|
| Planning for surge of COVID-19 patients | Created plans for medication distribution, clinical staffing, pharmacists training to cross cover, and preparation of the department for expansion to patient care areas not previously used (eg, dorms, convention center) | MS/HSPA Residents |
| Viral media for COVID-19 testing preparation | Prepared and packaged viral media for distribution to COVID-19 swab testing stations throughout the state to increase the capacity of tests completed per day | All Residents |
| Nonprescription swab station kits | Ordered, created, and distributed nonprescription medication kits at COVID-19 swab testing stations, including the front entrance of the hospital, to eliminate patients’ need to go to stores for symptomatic medications, such as antipyretic and cough suppressants | All Residents |
| COVID-19 call center | Volunteered at the COVID-19 call center where the mission was to stratify patients calling to see if the patient qualified for COVID-19 testing; if the patient qualified, the resident would place the COVID-19 testing order and direct the caller to the nearest swab station | All Residents |
| Airborne isolation code blue kits | Created crash cart kits with initial lifesaving medications that could be handed into a suspected or COVID-19 positive patient’s room during a code blue to limit additional personal protective equipment need and exposure to pharmacists | All Residents |
| Medication inventory management | Contributed to the drug shortage committee in creating innovative solutions to handle impending drug shortages such as reevaluating counts of drugs stored in crash carts and automated dispensing cabinets and reviewing concentrations of critical care drips to limit waste of medications | All Residents |
| Emergency department preparedness | While continuing to provide direct-patient care, participated in swab tents, education refreshers for emergency medicine nurses caring for critically ill patients and updated automated dispensing cabinet contents to minimize the number of medications dispensed from central pharmacy to ensure bundling of medication administration | PGY2 EM Residents |
| COVID-19 guideline development | Contributed to COVID-19 guideline development, including: • COVID-19 infectious diseases treatment guideline • Management of the critically ill COVID patient guideline ◦ Sedation and analgesia considerations in COVID-19 patients ◦ Pharmacologic treatment of acute respiratory distress syndrome • Blood conservation protocol • Recommendations on managing COVID-19 in cardiovascular disease • End-of-life palliative care protocols for COVID-19 patients • COVID-19 solid organ transplant treatment guideline • Transition of care document recommending proper steps for COVID-19–positive patients transitioning to outpatient settings | PGY2 Infectious Diseases, PGY2 Critical Care, PGY2 Cardiology, PGY2 Pain and Palliative, PGY2 Solid Organ Transplant, PGY2 Ambulatory Care Residents |
| STEMI treatment algorithm in COVID-19– positive or suspected patients | Created a thrombolytic for STEMI checklist and a thrombolytic STEMI dosing card, drafted a pharmacist progress note to document for services provided during a STEMI, constructed a STEMI order set for additional thrombolytics recently added to formulary, and provided education for pharmacists and providers involved in STEMI care | PGY2 Cardiology Residents |
| Department of pharmacy communication | Drafted daily COVID-19 update email that included “pharmacy brags” and updated treatment guidelines, drug shortage alerts, changes in hospital policies, and daily wellness activities that were sent out to the department of pharmacy | MS/HSPA Residents |
| Advocate for expansion of pharmacy services reimbursement | Drafted communication to distribute to payors to highlight the numerous telehealth services pharmacists can provide in hopes to further expand pharmacists’ provider status and reimbursement of services | PGY2 Ambulatory Care, MS/HSPA Residents |
| Conversion of ambulatory care services | Involved in converting face-to-face visits to telehealth options including phone or video visits and using alternate sites of care for patients (eg, drive-up international normalized ratio checks) and virtual transitions of care postdischarge for COVID-positive patients | PGY2 Ambulatory Care Residents |
Abbreviations: COVID-19, coronavirus disease 2019; HSPA, health-system pharmacy administration; PG, postgraduate; STEMI, ST-elevation myocardial infarction.